Exelixis (EXEL) EBITDA Margin Growth (5y) (2015 - 2026)
Exelixis (EXEL) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 4,285.00 |
| Jan 2, 2026 | 3,029.00 |
| Oct 3, 2025 | 5,800.00 |
| Jul 4, 2025 | 847.00 |
| Apr 4, 2025 | 1,037.00 |
| Jan 3, 2025 | -338.00 |
| Sep 27, 2024 | -1,733.00 |
| Jun 28, 2024 | 501.00 |
| Mar 29, 2024 | -3,231.00 |
| Dec 29, 2023 | -3,177.00 |
| Sep 29, 2023 | -5,926.00 |
| Jun 30, 2023 | -2,952.00 |
| Mar 31, 2023 | -4,737.00 |
| Dec 30, 2022 | -4,252.00 |
| Sep 30, 2022 | -3,316.00 |
| Jul 1, 2022 | -743.00 |
| Apr 1, 2022 | -157.00 |
| Oct 1, 2021 | 404.00 |
| Jul 2, 2021 | 10,127.00 |
| Apr 2, 2021 | 53,830.00 |